Best GLP-1 Providers in Mississippi (2026)

See by medication

Looking for a specific GLP-1? Browse Mississippi providers by drug.

About GLP-1s in Mississippi

Mississippi allows telehealth GLP-1 prescriptions. Mississippi Medicaid covers GLP-1s only for type 2 diabetes diagnosis.

• •Mississippi has the highest adult obesity rate in the US at 40.1%
• •Mississippi Medicaid restricts GLP-1 coverage to diabetes
• •Telehealth GLP-1 demand is extremely high statewide

Top Cities for GLP-1 Treatment in Mississippi

Telehealth providers ship to all Mississippi addresses, but demand is highest in these metro areas:

Prefer an in-person clinic? Browse the Mississippi GLP-1 clinic directory →

GLP-1 Care Access in Mississippi: The Numbers

Mississippi has 230 NPI-registered in-person weight-management clinics across 49 cities — 5 with an obesity-medicine taxonomy, 88 endocrinology, and 138 bariatric — alongside 78 telehealth programs that ship to Mississippi addresses. The cheapest verified ongoing compounded semaglutide price available to Mississippi residents is $79/mo (tirzepatide: $104/mo). Full methodology and the 50-state table: GLP-1 care access by state.

Insurance & Medicaid in Mississippi

In Q1 2026, Mississippi Medicaid reimbursed approximately $20,785,938 across 17,804 GLP-1 prescriptions (all covered indications, gross before rebates — federal SDUD data; full state series here).

Most insurance plans in Mississippi cover GLP-1s for type 2 diabetes (Ozempic, Mounjaro), but coverage for obesity-only indications (Wegovy, Zepbound) is much more limited and often requires prior authorization. If your insurance won't cover brand-name GLP-1s, compounded semaglutide through telehealth is typically the most affordable option at around $189/mo.

For the exact criteria, drug list, and appeal process, read our Mississippi Medicaid GLP-1 coverage & prior-authorization guide. For coverage backdoors, Zepbound is FDA-approved for obstructive sleep apnea, and Wegovy for kidney and cardiovascular indications, which some plans cover even when they exclude weight-loss-only use.

Obesity in Mississippi

According to CDC data, 40.1% of Mississippi adults have obesity (BMI of 30 or higher). This places Mississippi at #1 out of 50 states. Access to GLP-1 medications like semaglutide and tirzepatide has expanded significantly through telehealth, helping Mississippi residents get clinically supervised weight loss treatment from home.

To choose a medication, compare the clinical-trial results behind each drug, see our best semaglutide and tirzepatide provider rankings, or track the next-generation GLP-1 pipeline.

Frequently Asked Questions